排序方式: 共有94条查询结果,搜索用时 31 毫秒
1.
该实验采用保加利亚乳杆菌、嗜热链球菌、醋酸菌3种菌种发酵猴头菇,通过比较发酵液的DPPH自由基清除率,确定猴头菇发酵的最优条件。用猴头菇益生菌发酵液对酒精性胃溃疡模型的小鼠进行灌胃,测定胃溃疡小鼠胃组织中超氧化物歧化酶(SOD)、丙二醛(MDA)、过氧化氢酶(CAT)和血清中炎症因子白介素-6(IL-6)、白介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)含量。结果表明,最佳发酵条件为起始p H值6.5、菌种复配比(保加利亚乳杆菌:嗜热链球菌:醋酸菌)1:1:1、接种量8.8%、发酵温度37.5℃、发酵时间27 h,发酵液菌落数为8.72×109 CFU/mL、发酵液的DPPH自由基清除率可达79.59%。与模型组相比,高剂量组小鼠胃组织的SOD和CAT水平分别升高了71.38%和99.89%、MDA含量降低了47.45%;小鼠血清中的炎症因子TNF-α和IL-6含量分别降低了32.66%和34.95%、IL-10含量升高了100.46%,表明猴头菇益生菌发酵液对小鼠的急性酒精性胃溃疡有保护作用。该研究为猴头菇的应用提供了理论支持,为猴头菇新产品的开拓和益... 相似文献
2.
猴头菌是传统的食药两用菌,具有猴头菌多糖、猴头菌素、猴头菌酮、麦角甾醇等多种活性成分,对胃炎、胃溃疡、胃癌等胃部疾病具有有益调节作用。猴头菌有子实体和菌丝体两种形态,菌丝体又分为固态发酵菌丝体与液态发酵菌丝体。本文主要对比阐述了猴头菌子实体与液态发酵菌丝体活性成分差异以及它们在改善胃部疾病中相关研究成果,以期为猴头菌液态发酵菌丝体规模化、工业化、自动化生产,以及功能食品和食用菌基天然药物的开发提供依据和参考。 相似文献
3.
猴头菌发酵刺五加后多糖与紫丁香苷的含量变化研究 总被引:1,自引:0,他引:1
研究猴头菌发酵刺五加后多糖及紫丁香苷的含量变化,为新药源开发提供理论依据。以蒽酮-硫酸法测定猴头菌发酵刺五加前后多糖的含量,并采用高效液相色谱法对发酵前后紫丁香苷的含量进行检测。结果显示,猴头菌发酵刺五加后多糖的质量分数由发酵前的0.3%提高到0.7%,多糖的含量提高了133%;而刺五加原药材中紫丁香苷的含量为0.0096%,发酵后在紫丁香苷标准峰对应处未出峰,而是在其它位置出现了三个新的谱带。猴头菌发酵刺五加后多糖含量显著提高,可以起到协同或增加猴头菌及刺五加药效的作用;发酵物中紫丁香苷成分未检出,是由于发酵后紫丁香苷在微生物酶的作用下降解转化为其它物质,有利于提高生物利用度,为新药源的开发奠定了基础。 相似文献
4.
5.
对猴头菇子实体多糖进行纯化研究。采用树脂吸附法对猴头菇多糖脱色并利用超滤法进行分级除杂。结果表明:猴头菇多糖适宜采用HD-3树脂进行脱色;静态脱色工艺为pH4.5、每100mL添加树脂量15.0g、脱色2.5h,脱色率和多糖得率分别达到84.9%和83.2%;动态脱色工艺控制流速为5BV/h时,脱色率和多糖得率都较高,平均达83.9%和82.3%;最佳超滤工艺为选择截留分子质量为10kD 和100kD的两种膜对猴头菇多糖进行超滤,超滤温度45℃、压力0.16MPa、溶液pH7~9。此工艺适合工业化生产的需要,得到的猴头菇多糖纯度达74.2%。 相似文献
6.
7.
8.
建立气相色谱-串联质谱(GC-MS/MS)法测定猴头菇中16种农药残留的定性、定量分析检测方法。样品经乙腈旋涡振荡提取、净化、浓缩、过滤、定容后,采用气相色谱串联质谱进行定性、定量检测分析。结果表明,16种农药在质量浓度为0.05~1.00 μg/mL范围内的线性关系良好,相关系数(R2)为0.998 6~0.999 9。在猴头菇样品中分别添加质量浓度为0.05 mg/kg、0.20 mg/kg、0.40 mg/kg的混合农药组分,平均回收率为86.08%~93.63%,相对标准偏差(RSD)为3.96%~8.92%,检出限为0.010~0.075 mg/kg。该法操作便捷、灵敏度高、回收率良好、精密度可靠,适用于猴头菇中多种有机农药残留的同时检测。 相似文献
9.
10.
Xiao-Yin Wang Duo-duo Zhang Shao-Ping Nie 《Critical reviews in food science and nutrition》2019,59(11):S96-S115
AbstractHericium erinaceus (H. erinaceus), an edible mushroom with medicinal value, has a long history of usage in China and other oriental countries. Polysaccharide is supposed to be one of the major bioactive compounds in H. erinaceus, which possesses immunomodulating, anti-cancer, antioxidant, gastroprotection and intestinal health promotion, neuroprotective, hepatoprotective, antihpyerglycemic and hypolipidemic activities. In this review, the current advancements on extraction, purification, structural characteristics and biological activities of polysaccharide from different sources (fruiting body, mycelium and culture broth) of H. erinaceus were summarized. Among these aspects, summaries of the structural characteristics focused on the purified polysaccharides. Meanwhile, comparisons on the structural characteristics among the purified polysaccharides obtained from above three sources were made. Moreover, their biological activities were introduced on the basis of in vivo and in vitro experiments, and some possible action mechanisms were listed. Furthermore, the structure-activity relationship of the polysaccharide was discussed. New perspectives for the future work of Hericium erinaceus polysaccharide were also proposed.
- HIGHLIGHTS
Extraction, purification, structural characteristics and biological activities of Hericium erinaceus polysaccharide (HEP) were summarized.
Structural characteristics of the purified polysaccharides from different sources (fruiting body, mycelium and culture broth) of Hericium erinaceus were summarized and compared.
Structure-activity relationship of HEP was discussed, and new perspectives for the future work of this polysaccharide were proposed.